An industrial company with an impenetrable market position in an oligopoly business and a healthcare equipment supplier with a leading market share and an honest management team that returns cash to stockholders is a winning combination of investments. Read More
Jim Fink is chief investment strategist for Options for Income, Velocity Trader, and Jim Fink's Inner Circle. He has traded options for more than 30 years and generated personal profits of more than $5 million. Jim also serves as an investment analyst at Investing Daily’s flagship investing publication, Personal Finance.
Hopelessly overeducated, Jim holds a bachelor's degree from Yale University, a master's degree from Harvard's Kennedy School of Government, a law degree from Columbia University, and an MBA from the University of Virginia's Darden School of Business. For good measure, he has been a member of the Illinois and D.C. bars.
Prior to joining Investing Daily, and when not incurring student loans hiding out in academe, Jim practiced telecommunications regulatory law for nine years until he realized that he made more money trading stock options than writing briefs. After attending business school, Jim switched gears to the investment realm full-time, working for a university endowment, a private wealth management firm, an insurance and financial planning company, and as a Senior Analyst for an online investment newsletter service that encourages the wearing of funny hats.
A possible but unlikely descendant of legendary brawler and boatman Mike Fink, Jim defies his heritage, believing that investing success requires patience and analysis, not swashbuckling bravado. Besides his passion for analyzing and writing about stocks, Jim likes to hike in the desert Southwest, vacation in Las Vegas, play tennis, and feed his toddler son Cheerios.
Analyst Articles
An autumn market correction followed by new all-time highs is a likely scenario. Read More
More Roadrunner companies report Q2 earnings, including a tech company ready to make a roaring comeback and a biotech company offering up an incredibly optimistic forecast. Read More
Sick and tired of the "doom and gloomers?" If investors were to implement the Ivy timing system, these chicken littles would go out of business in a flash. Read More
In the July issue of Roadrunner Stocks, two new BUY recommendations have been issued. 1. The Value Portfolio is adding defense technology contractor ManTech International (MANT)2. The Momentum Portfolio is adding educational toy manufacturer LeapFrog Enterprises (LF) Read More . . . Read More
Second-quarter earnings for several Roadrunner companies have come in better than expected. Read More
High technology permeates all industries, ranging from defense to children's education. These two small caps are leveraging their technological expertise into a long runway of strong future growth. Get in now while the stock valuations remain cheap and before most investors "catch on" to their high-growth stories. Read More
With the stock market hitting new all-time highs, the odds favor being long and strong through the end of the year. Read More
The current bull market in stocks is like an ocean that raises all boats -- even boats that are likely to sink. Avoiding such fair-weather investments is the key to investment success and the Roadrunner Stocks Safety Rating can help lead the way. Read More
The current bull market in stocks is like an ocean that raises all boats -- even boats that are likely to sink. Avoiding such fair-weather investments is the key to investment success and the Roadrunner Stocks Safety Rating can help lead the way. Read More